CISP caused significant up-regulation of the CD8+/CD4+ ratio in the TdLNs, which was reported to associated with the prognosis of a variety of cancers and the response to immunotherapy43 (Supplementary Fig. 41a, b). The gene discussed is CD8A; the disease is cancer.